Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Options -- Ignore unavailable to you. Want to Upgrade?

To: Teflon who wrote (5109)	3/16/2000 9:10:00 AM
From: Jill	Respond to of 8096

Yes...maybe next week would be good for meeting. I believe garyx is a NYer too, he could also join us? I've been mulling over AFFX. My timing was truly careless but I still think my choice wasgood, and I'm thinking of going long some lower strike calls. I understand the biotech sector was overbought, but even if the news was misunderstood for most companies, AFFX will benefit from a national initiative for free gene research, or from private company support. E ither way, they make the chips for the research. This was posted over on SNDK thread from Ind Investor: Other companies that are attractive following include Affymetrix (NASDAQ: AFFX - Quotes, News, Boards) a genomics play that will benefit from open access to genomics data. With its patented GeneChip products, Affymetrix is uniquely positioned to benefit from the expanding market for gene expression analysis.